Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
50.08
+0.96 (1.95%)
At close: Jun 26, 2026, 4:00 PM EDT
50.00
-0.08 (-0.16%)
After-hours: Jun 26, 2026, 7:57 PM EDT
Enliven Therapeutics Employees
Enliven Therapeutics had 60 employees as of December 31, 2025. The number of employees decreased by 2 or -3.23% compared to the previous year.
Employees
60
Change (1Y)
-2
Growth (1Y)
-3.23%
Revenue / Employee
n/a
Profits / Employee
-$1,619,295
Market Cap
3.50B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 60 | -2 | -3.23% |
| Dec 31, 2024 | 62 | 16 | 34.78% |
| Dec 31, 2023 | 46 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ultragenyx Pharmaceutical | 1,371 |
| Tarsus Pharmaceuticals | 370 |
| Arcutis Biotherapeutics | 354 |
| Vera Therapeutics | 339 |
| Dyne Therapeutics | 263 |
| Alumis | 227 |
| uniQure | 221 |
| Celldex Therapeutics | 198 |
ELVN News
- 12 days ago - Enliven Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares - PRNewsWire
- 15 days ago - Why Is Enliven Therapeutics Stock (ELVN) Up Today? - TipRanks
- 15 days ago - Enliven rises 9.9% - TheFly
- 16 days ago - Enliven Therapeutics Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants - PRNewsWire
- 16 days ago - Enliven announces $250M common stock offering - TheFly
- 16 days ago - Enliven Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - PRNewsWire
- 17 days ago - Enliven rises 14.8% - TheFly
- 17 days ago - Enliven Therapeutics Transcript: Study update - Transcripts